Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(19):1421; doi:10.1093/jnci/djm184
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Fruit and Vegetable Intake and Colon Cancer Risk

Previous epidemiologic studies of the association between fruit and and vegetable intake and the risk of colon cancer have been inconsistent. Koushik et al. (p. 1471) analyzed 14 prospective cohort studies and then pooled their results to examine the association between total fruit and/or total vegetable intake and the risk of colon cancer overall, as well as proximal and distal colon cancer separately after adjusting for other colon cancer risk factors. There was little association between intake of fruits and vegetables and the overall risk of colon cancer. However, there was . . . [Full Text of this Article]

Alternative Design of Phase II Trials for New Cancer Therapies

Performance of New Screening Tests for Colorectal Neoplasms

Prostate Cancer Detection on Biopsy: Location vs. Number

"Cancer Stem Cells" or "Cancer-Initiating Cells"?

Drug Resistance and the Solid Tumor Microenvironment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Drug Resistance and the Solid Tumor Microenvironment
Olivier Trédan, Carlos M. Galmarini, Krupa Patel, and Ian F. Tannock
J Natl Cancer Inst 2007 99: 1441-1454. [Abstract] [Full Text] [PDF]

"Destemming" Cancer Stem Cells
Richard P. Hill and Roberto Perris
J Natl Cancer Inst 2007 99: 1435-1440. [Abstract] [Full Text] [PDF]

Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
James E. Allison, Lori C. Sakoda, Theodore R. Levin, Jo P. Tucker, Irene S. Tekawa, Thomas Cuff, Mary Pat Pauly, Lyle Shlager, Albert M. Palitz, Wei K. Zhao, J. Sanford Schwartz, David F. Ransohoff, and Joseph V. Selby
J Natl Cancer Inst 2007 99: 1462-1470. [Abstract] [Full Text] [PDF]

Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence
Gabriel P. Haas, Nicolas Barry Delongchamps, Richard F. Jones, Vishal Chandan, Angel M. Serio, Andrew J. Vickers, Mary Jumbelic, Gregory Threatte, Rus Korets, Hans Lilja, and Gustavo de la Roza
J Natl Cancer Inst 2007 99: 1484-1489. [Abstract] [Full Text] [PDF]

Fruits, Vegetables, and Colon Cancer Risk in a Pooled Analysis of 14 Cohort Studies
Anita Koushik, David J. Hunter, Donna Spiegelman, W. Lawrence Beeson, Piet A. van den Brandt, Julie E. Buring, Eugenia E. Calle, Eunyoung Cho, Gary E. Fraser, Jo L. Freudenheim, Charles S. Fuchs, Edward L. Giovannucci, R. Alexandra Goldbohm, Lisa Harnack, David R. Jacobs, Jr, Ikuko Kato, Vittorio Krogh, Susanna C. Larsson, Michael F. Leitzmann, James R. Marshall, Marjorie L. McCullough, Anthony B. Miller, Pirjo Pietinen, Thomas E. Rohan, Arthur Schatzkin, Sabina Sieri, Mikko J. Virtanen, Alicja Wolk, Anne Zeleniuch-Jacquotte, Shumin M. Zhang, and Stephanie A. Smith-Warner
J Natl Cancer Inst 2007 99: 1471-1483. [Abstract] [Full Text] [PDF]

Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non–Small-Cell Lung Cancer
Theodore G. Karrison, Michael L. Maitland, Walter M. Stadler, and Mark J. Ratain
J Natl Cancer Inst 2007 99: 1455-1461. [Abstract] [Full Text] [PDF]

Which Colorectal Cancer Screening Test Is Best?
Jack S. Mandel
J Natl Cancer Inst 2007 99: 1424-1425. [Extract] [Full Text] [PDF]

Early Average Change in Tumor Size in a Phase 2 Trial: Efficient Endpoint or False Promise?
Larry V. Rubinstein, Janet E. Dancey, Edward L. Korn, Malcolm A. Smith, and John J. Wright
J Natl Cancer Inst 2007 99: 1422-1423. [Extract] [Full Text] [PDF]